ClinicalTrials.Veeva

Menu

Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps for Acute Peptic Ulcer Bleeding

K

Kyung Hee University

Status

Completed

Conditions

Active Peptic Ulcer Disease/GI Bleeding

Treatments

Device: epinephrine injection plus soft coagulation using hemostatic forceps
Device: epinephrine injection plus argon plasma coagulation

Study type

Interventional

Funder types

Other

Identifiers

NCT02020603
GUB2013

Details and patient eligibility

About

Endoscopic high-frequency soft coagulation is available for the management of bleeding or nonbleeding visible vessels during endoscopic submucosal dissection. However, its efficacy on peptic ulcer bleeding has not been elucidated so far. The aim of this study was to evaluate the efficacy of hemostasis with soft coagulation using hemostatic forceps by comparing it with argon plasma coagulation (APC) in a prospective, randomized trial.

Enrollment

151 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age greater than 18 years
  • peptic ulcer with stigmata of recent hemorrhage

Exclusion criteria

  • malignant ulcer
  • previous gastric surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

151 participants in 2 patient groups

APC group
Active Comparator group
Description:
epinephrine injection plus argon plasma coagulation
Treatment:
Device: epinephrine injection plus argon plasma coagulation
Forceps group
Active Comparator group
Description:
epinephrine injection plus soft coagulation using hemostatic forceps
Treatment:
Device: epinephrine injection plus soft coagulation using hemostatic forceps

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems